Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
KYMR compared with ALKS: revenue, margins and what each company keeps, and the suppliers and customers both name
KYMR
Kymera Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
ALKS
Alkermes plc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
KYMR
Kymera Therapeutics, Inc.
vs
ALKS
Alkermes plc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
KYMR, solid
ALKS, dashed
KYMR
Kymera Therapeutics, Inc.
Change
127.54
▲
+0.02%
· post 127.11
· delayed
Mkt cap
$10.9B
Revenue
$65M
Q2 FY26
Revenue
$39M
FY25
ALKS
Alkermes plc.
Change
45.80
▲
+2.02%
· post 45.83
· delayed
After hours
Nov 3 '26
delayed
Mkt cap
$7.5B
Revenue
$480M
Q3 FY26
Revenue
$1.5B
FY25
vs
Compare
After hours
Nov 3 '26
delayed
KYMR
Kymera Therapeutics, Inc.
vs
ALKS
Alkermes plc.
127.54
▲
+0.02%
post 127.11
delayed
Price
45.80
▲
+2.02%
post 45.83
delayed
$10.9B
Mkt cap
$7.5B
Q2 FY26
$65M
Revenue
$480M
Q3 FY26
FY25
$39M
Revenue
$1.5B
FY25
Change
Change
KYMR
127.54
▲
+0.02%
vs
ALKS
45.80
▲
+2.02%
After hours
Nov 3 '26
delayed